Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx s...
Read moreUn estudio publicado en la revista ‘Leukemia’ demuestra que algunos casos de leucemia mieloide aguda infantil surgen antes del nacimiento, durante el desarrollo fetal
Read moreEste innovador dispositivo no invasivo, presentado ayer en las instalaciones del FC Barcelona, tiene forma de banda pectoral y registra, procesa y muestra, en tiempo real y de forma continua y remota,...
Read moreIrsiCaixa, as coordinator of the international consortium IciStem, has led a pioneering study that highlights which factors trigger the reduction of the HIV reservoir after a stem cell transplant
Read moreResearchers from Sant Joan de Déu have promoted various research projects in recent years to advance the understanding of Prader-Willi syndrome and study new treatments for children affected by this ...
Read moreResearchers from the Clínic-IDIBAPS took part in an international study that identified a specific type of fibroblast, called CD200+, which plays a key role in the resolution of joint inflammation in...
Read moreHan relacionado el gen NUDCD3 con dos inmunodeficiencias severas en niños, el síndrome de inmunodeficiencia combinada severa (SCID) y el síndrome de Omenn. Los resultados de su estudio podrían sup...
Read moreEl tratamiento invasivo, frente al conservador, no reduce la mortalidad, pero sí el riesgo de un nuevo infarto o la necesidad de un cateterismo urgente
Read moreUn estudio experimental en ratones puede suponer un avance en la lucha contra la resistencia a estos medicamentos. El nuevo fármaco, llamado lolamicina, mata a los microbios infecciosos sin interferi...
Read moreInvestigadores del Cima demuestran en modelos animales que los aptámeros de CD3 estimulan la expansión de linfocitos T durante la terapia celular adoptiva
Read moreAdcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, today announces t...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read more